Literature DB >> 12353965

Infliximab-induced systemic lupus erythematosus.

Yousaf Ali, Samir Shah.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12353965     DOI： 10.7326/0003-4819-137-7-200210010-00030

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

Review 1.  TREG-cell therapies for autoimmune rheumatic diseases.

Authors:  Makoto Miyara; Yoshinaga Ito; Shimon Sakaguchi
Journal:  Nat Rev Rheumatol       Date:  2014-07-01       Impact factor: 20.543

Review 2.  Psoriatic arthritis treatment: biological response modifiers.

Authors:  P J Mease; C E Antoni
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

3.  Etanercept-induced systemic lupus erythematosus in a patient with rheumatoid arthritis.

Authors:  Min-Jung Kang; You-Hyun Lee; Jisoo Lee
Journal:  J Korean Med Sci       Date:  2006-10       Impact factor: 2.153

4.  Treatment of refractory psoriatic arthritis with infliximab: a 12 month observational study of 16 patients.

Authors:  M Feletar; J E Brockbank; C T Schentag; V Lapp; D D Gladman
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

5.  Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment.

Authors:  Francesca Bobbio-Pallavicini; Claudia Alpini; Roberto Caporali; Stefano Avalle; Serena Bugatti; Carlomaurizio Montecucco
Journal:  Arthritis Res Ther       Date:  2004-04-26       Impact factor: 5.156
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.